Christopher And Dana Reeve Foundation Response To FDA Clearance Of Geron's Clinical Trial

Main Category: Stem Cell Research
Article Date: 24 Jan 2009 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

3.75 (4 votes)

Healthcare Prof:not yet rated


Peter T. Wilderotter, president and CEO of the Christopher & Dana Reeve Foundation, issued the following statement in response to FDA clearance of Geron's human clinical trial of embryonic stem cell-based therapy:

"This is an exciting first step for Geron and for spinal cord injured patients whose lives may improve due to advances in medical research. There has been so much speculative and unsubstantiated information about the use of stem cells in spinal cord injury; it is important to study these cells in a rigorously designed clinical trial that is monitored by the FDA."

Wilderotter continued, "Christopher and Dana Reeve brought national attention to this issue and they gave voice to all those who are suffering the devastating physical, emotional and financial impact of challenging neurological conditions. Their belief in the promise of stem cell research became a part of their lasting legacy."

Shortly before his death, Christopher Reeve wrote, "It is our responsibility to do everything possible to protect the quality of life of the present and future generations...No obstacle should stand in the way of responsible investigation of their [stem cells] possibilities."

Wilderotter concluded, "This is the dawn of basic research being translated into human clinical trials for people living with spinal cord injury. We are hopeful that what is learned from the results will enable us to move forward with therapies for people living with spinal cord injuries."

About the Reeve Foundation

The Christopher and Dana Reeve Foundation is dedicated to curing spinal cord injury by funding innovative research, and improving the quality of life for people living with paralysis through grants, information and advocacy

The Christopher and Dana Reeve Foundation
http://www.christopherreeve.org

Article adapted by Medical News Today from original press release.
Visit our stem cell research section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
The Christopher and Dana Reeve Foundation. "Christopher And Dana Reeve Foundation Response To FDA Clearance Of Geron's Clinical Trial." Medical News Today. MediLexicon, Intl., 24 Jan. 2009. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/136554.php>

APA
The Christopher and Dana Reeve Foundation. (2009, January 24). "Christopher And Dana Reeve Foundation Response To FDA Clearance Of Geron's Clinical Trial." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/136554.php.

Please note: If no author information is provided, the source is cited instead.


Stem Cell Research

What are Stem Cells?

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: embryonic stem cells and adult stem cells Read more...

Most Popular Articles



Follow Our Stem Cell Research News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Stem Cell Research Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »